Jason comes to Endpoints after some globetrotting years as a journalist and teacher. He's interested in the emerging fields of gene therapy and psychedelic research. A graduate of Northwestern University, he previously worked for Bloomberg BNA, the Weekend Argus in Cape Town and the Chautauquan Daily. Outside of biopharma, he loves dogs (especially labradors), the writer Charles D'Ambrosio, and the New York Mets.
Sign up for free to read a limited number of articles each month.About You
Pick what newsletters get delivered to your inbox each week.
Want unlimited access? Sign up for a premium subscription plan.
Join over 187,300 biopharma colleagues who rely on Endpoints News every business day for the latest developments in drug discovery, development, and commercialization.